Suchergebnisse - "Pan, Yueyin"

PubPharm (164)

1

Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6) : single-arm, open-label, multicentre, phase 2 trial

enthalten in: The Lancet. Respiratory medicine | 2024

von Wang, M. | Fan, Y. | Sun, M. | +37

2

First-line sugemalimab with chemotherapy for advanced esophageal squamous cell carcinoma : a randomized phase 3 study

enthalten in: Nature medicine | 2024

von Li, J. | Chen, Z. | Bai, Y. | +29

3

Clinical Outcomes and Intrinsic Subtypes of Breast Cancer Patients with Single Hormone Receptor-positive Receiving Neoadjuvant Chemotherapy

enthalten in: Clinical breast cancer | 2024

von Wang, T. | Wang, J. | Zhao, W. | +1

4

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK-029A in Treatment-Naive Patients With Advanced NSCLC Harboring EGFR Exon 20 Insertion Mutations : A Phase 1 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Duan, J. | Wu, L. | Yang, K. | +32

5

Myeloprotection with trilaciclib in Chinese patients with extensive-stage small cell lung cancer receiving chemotherapy : Results from a randomized, double-blind, placebo-controlled phase III study (TRACES)

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Cheng, Y. | Wu, L. | Huang, D. | +22

6

First-line treatment with camrelizumab plus famitinib in advanced or metastatic NSCLC patients with PD-L1 TPS ≥1% : results from a multicenter, open-label, phase 2 trial

enthalten in: Journal for immunotherapy of cancer | 2024

von Ren, S. | Wang, X. | Han, B. | +19

7

A global phase 3 study of serplulimab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (ASTRUM-004)

enthalten in: Cancer cell | 2024

von Zhou, C. | Hu, Y. | Arkania, E. | +24

CommentIn: Cancer Cell. 2024 Feb 12;42(2):172-174. - PMID 38350419

8

First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302) : a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial

enthalten in: The Lancet. Respiratory medicine | 2024

von Zhong, H. | Sun, S. | Chen, J. | +41

9

Myeloid PTEN loss affects therapeutic response by promoting stress granules assembly and impairing phagocytosis of macrophages in breast cancer

enthalten in: ResearchSquare.com | 2024

von Pan, Y. | Li, Y. | Wang, G. | +9

10

Myeloid PTEN loss affects therapeutic response by promoting stress granules assembly and impairing phagocytosis of macrophages in breast cancer

enthalten in: ResearchSquare.com | 2024

von Pan, Y. | Li, Y. | Wang, G. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]